GHW International (HKG:9933)

Market Cap	1.51B +4.0%
Revenue (ttm)	4.58B +6.5%
Net Income	14.15M -0.3%
EPS	0.01 -3.8%
Shares Out	945.22M
PE Ratio	110.60
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,000
Average Volume	143,400
Open	1.630
Previous Close	1.650
Day's Range	1.600 - 1.640
52-Week Range	1.160 - 2.640
Beta	0.49
RSI	44.69
Earnings Date	Aug 25, 2026

About GHW International

GHW International, an investment holding company, manufactures and sells chemical and pharmaceutical products in the People’s Republic of China, Europe, Vietnam, rest of Asia, and internationally. It operates through seven segments: Methylamine Industry Series, Applied Chemicals Series, Advanced Materials Intermediates Series, Green Products, Pharmaceutical intermediates and Active Pharmaceutical ingredients (“APIs”), Iodine Derivatives and Supporting products, and Happy Elephant Planet, Advanced Medical and Health Products segments. The Methyl...

• Industry: Chemicals
• Sector: Materials
• Founded: 1995
• Employees: 1,109
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9933

Financial Performance

In 2025, GHW International's revenue was 4.11 billion, an increase of 6.51% compared to the previous year's 3.86 billion. Earnings were 12.72 million, a decrease of -0.28%.

Financial numbers in CNY